Abstract
This study evaluates the effectiveness of six machine learning classifiers—Support Vector Classifier (SVC), Logistic Regression, K-Nearest Neighbors (KNN), Naive Bayes, Decision Tree, and Random Forest—in detecting brain tumors using numerical data rather than traditional imaging techniques like MRI. The results emphasize the importance of data preprocessing, particularly feature scaling, in enhancing model performance. Among the classifiers, Random Forest emerged as the top performer, achieving an accuracy of 98.27% on both original and scaled data, demonstrating its robustness and reliability. The study highlights the potential of Random Forest as a valuable tool for automated brain tumor detection in clinical settings, offering a cost-effective and accessible alternative for resource-constrained environments. The paper suggests that future research should explore advanced deep learning models, such as 3D Convolutional Neural Networks (CNNs) and Generative Adversarial Networks (GANs), to further improve diagnostic accuracy and support early intervention and personalized treatment strategies for brain tumor patients.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Protocols
https://github.com/1umairali/models/blob/main/brain_tumor_detection/brain_dataset.csv
https://www.kaggle.com/datasets/jakeshbohaju/brain-tumor
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Dataset downloaded from: https://github.com/1umairali/models/tree/main/brain_tumor_detection https://www.kaggle.com/datasets/jakeshbohaju/brain-tumor
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
I am pleased to resubmit my revised manuscript, which addresses the concerns and errors identified in the previous version. Specifically: - I apologize for the oversight, but the abstract was not updated in this revised version. I will make sure to revise it accordingly in the next submission. I have carefully reviewed the manuscript to ensure accuracy, completeness, and consistency. I believe these revisions strengthen the manuscript and provide a clearer presentation of my research.
